Braveheart Bio, Inc. (BRVE)
29.20
+1.49
(+5.38%)
USD |
NASDAQ |
Sep 18, 16:00
28.95
-0.25
(-0.86%)
After-Hours: 20:00
Braveheart Bio Net Income (Quarterly) : -14.99M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -14.99M |
| March 31, 2026 | -14.28M |
| Date | Value |
|---|---|
| June 30, 2025 | -0.381M |
| March 31, 2025 | -0.099M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Bristol Myers Squibb Co. | 3.316B |
| ANI Pharmaceuticals, Inc. | 23.00M |
| Corcept Therapeutics, Inc. | 42.14M |
| Veru, Inc. | -6.988M |
| IGC Pharma, Inc. | -2.936M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 14.99M |
| EPS Diluted (Quarterly) | -0.2066 |
| Enterprise Value | 2.720B |
| Earnings Yield | -1.27% |
| Normalized Earnings Yield | -1.264 |